Omid Seidizadeh/LinkedIn
Oct 23, 2025, 06:48
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn:
”Happy to share our new publication in RPTH Journal
Our study integrates clinical, biochemical, and structural data to uncover how A2 domain variants drive disease through impaired multimerization, altered proteolysis, and increased clearance.
A great collaboration with Dr. Luca Mollica and the team!”
Read the full article in RPTH.
Article: Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD with VWF A2 Domain Mutations
Authors: Omid Seidizadeh, Luca Mollica, Davide Giana, Luciano Baronciani, Paola Colpani, Lea Sicuro, Andrea Cairo, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis